ARCHIVES

Lenalidomide, An Altered Thalidomide, Shows Promise

This article is from The Cancer Letter archive.

Vol. 29 No. 11 | November 24, 2006

Download PDF Visit The Full Archive

Related Articles

Ilex Oncology Buys Symphar, Controls Drug For Bone Mets.

March 2, 2001

Wilex, Fox Chase, Begin Trial Of WX-UK1 Targeting Invasion

May 28, 2004

Intergroup 5-FU/Levamisole Study Positive Enough Now To End Untreated Control Arms

September 22, 1989

SAIC Awarded $5 Billion Contract For NCI-Frederick.

October 3, 2008

Obama Executive Order Gives FDA Authority To Combat Drug Shortages

November 4, 2011

World Conference To Consider Smoking Problem, Research, Action

March 14, 1975